Cargando…
Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia
BACKGROUND: We evaluated if the survival benefit of adding rituximab to standard chemotherapy for non-Hodgkin lymphoma (NHL) observed in clinical trials has been experienced by an Australian NHL patient population. METHODS: NHL cases diagnosed in 1985-2004 in New South Wales (NSW) were followed-up t...
Autores principales: | Yu, Xue Q, Chen, Wendy H, O'Connell, Dianne L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886045/ https://www.ncbi.nlm.nih.gov/pubmed/20497580 http://dx.doi.org/10.1186/1471-2407-10-231 |
Ejemplares similares
-
Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia
por: Brennan, P, et al.
Publicado: (2000) -
Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study
por: Yu, Xue Qin, et al.
Publicado: (2017) -
Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997–2006
por: Woods, Laura M., et al.
Publicado: (2016) -
Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia
por: Rodger, Jennifer C., et al.
Publicado: (2015) -
Survival from non-Hodgkin lymphoma in England and Wales up to 2001
por: Johnson, P W M
Publicado: (2008)